MALINVERNO, FEDERICA
 Distribuzione geografica
Continente #
NA - Nord America 1.528
EU - Europa 794
AS - Asia 141
SA - Sud America 2
Totale 2.465
Nazione #
US - Stati Uniti d'America 1.514
IT - Italia 192
DE - Germania 186
SE - Svezia 128
IE - Irlanda 108
CN - Cina 78
AT - Austria 69
BE - Belgio 32
GB - Regno Unito 27
MY - Malesia 16
CA - Canada 14
DK - Danimarca 11
UA - Ucraina 11
HK - Hong Kong 10
NL - Olanda 9
VN - Vietnam 9
FR - Francia 8
IN - India 8
FI - Finlandia 6
TR - Turchia 6
MM - Myanmar 4
TW - Taiwan 3
GR - Grecia 2
KR - Corea 2
RU - Federazione Russa 2
AR - Argentina 1
BR - Brasile 1
EE - Estonia 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
PH - Filippine 1
PK - Pakistan 1
RO - Romania 1
SG - Singapore 1
Totale 2.465
Città #
Ann Arbor 496
Frankfurt am Main 172
Chandler 167
Fairfield 131
Dublin 105
Wilmington 99
Woodbridge 82
Ashburn 67
Seattle 66
Vienna 66
New York 55
Milan 53
Houston 46
Cambridge 42
Princeton 36
Brussels 31
Shanghai 31
Dearborn 29
Lawrence 18
Penang 16
Nanjing 13
Rome 12
Altamura 11
Jacksonville 11
Hong Kong 10
San Diego 10
London 7
Boardman 6
Buffalo 6
Toronto 6
Fremont 5
Helsinki 5
Lissone 5
Pune 5
Appiano Gentile 4
Dong Ket 4
Kocaeli 4
Udine 4
Andover 3
Biassono 3
Edmonton 3
Falls Church 3
Genoa 3
Hebei 3
Jinan 3
Kunming 3
Modena 3
New Taipei 3
Shenyang 3
Vigevano 3
Athens 2
Bari 2
Beijing 2
Bergamo 2
Bonndorf 2
Castelnuovo Scrivia 2
Catania 2
Changsha 2
Dalmine 2
Franklin 2
Groningen 2
Guangzhou 2
Guiyang 2
Hanover 2
Lucera 2
Meda 2
Monza 2
Mumbai 2
Nanchang 2
Ningbo 2
Norwalk 2
Padova 2
Paris 2
Pavia 2
Sacramento 2
Tianjin 2
Triggiano 2
Wuhan 2
Amsterdam 1
Ankara 1
Arnsberg 1
Avigliana 1
Belsize Park 1
Bologna 1
Bresso 1
Busto Arsizio 1
Chapel Hill 1
Chicago 1
Chuo 1
Collegeville 1
Crespino 1
Daejeon 1
Delhi 1
Florence 1
Gallarate 1
General Santos 1
Grumo Nevano 1
Haikou 1
Hangzhou 1
Huntington Beach 1
Totale 2.050
Nome #
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score 426
A worldwide cross-ethnic study of quality of life in patients with PBC: Attitude or latitude? 287
FRI-008-Incidence, prevalence and mortality of primary sclerosing cholangitis in Italy: A population-based study 186
THU-010-Shedding light on the X chromosome contribution to the genetic architecture of primary biliary cholangitis 172
Prevention of hepatitis C recurrence by bridging sofosbuvir/ribavirin from pre- to post-liver transplant: A real-life strategy 170
Novel therapeutics for primary biliary cholangitis: Toward a disease-stage-based approach 162
From pathogenesis to novel therapies in the treatment of primary biliary cholangitis 160
Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis 160
Additive beneficial effects of Fibrates combined with Obeticholic acid in the treatment of patients with Primary Biliary Cholangitis and inadequate response to second-line therapy: data from the Italian PBC Study Group 153
Accuracy of Transient Elastography in assessing fibrosis at diagnosis in naïve patients with Primary Biliary Cholangitis: a dual cut-off approach 146
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 123
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 83
Long-term impact of preventive UDCA therapy after transplantation for primary biliary cholangitis 76
Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy 68
Comprehensive review of autoantibodies in patients with hyper-IgM syndrome 60
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 52
Real-world experience with obeticholic acid in patients with primary biliary cholangitis 51
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 49
Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis 45
Totale 2.629
Categoria #
all - tutte 7.566
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.566


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201978 0 0 0 0 0 0 0 0 12 14 24 28
2019/2020393 25 33 18 41 45 40 48 33 39 32 30 9
2020/2021612 12 12 102 37 37 97 61 66 43 40 60 45
2021/2022408 44 45 57 39 31 27 10 33 19 17 29 57
2022/2023683 60 196 63 70 73 56 34 36 47 14 28 6
2023/2024328 22 16 12 42 42 110 71 13 0 0 0 0
Totale 2.629